Norbert Sprenger1, Hannah Odenwald2,3,4, Anna Kaarina Kukkonen5, Mikael Kuitunen6, Erkki Savilahti6, Clemens Kunz7. 1. Nestlé Research Center, Nestec S.A., Vers-Chez-Les-Blanc, 1000, Lausanne 26, Switzerland. Norbert.Sprenger@rdls.nestle.com. 2. Nestlé Research Center, Nestec S.A., Vers-Chez-Les-Blanc, 1000, Lausanne 26, Switzerland. 3. Institute of Nutritional Sciences, University of Giessen, Wilhelmstr. 20, 35392, Giessen, Germany. 4. Nestle Health Sciences, Biopole, 1066, Epalinges, Switzerland. 5. Skin and Allergy Hospital, Helsinki University Central Hospital, 00029, Helsinki, Finland. 6. Children's Hospital, University of Helsinki and Helsinki University Central Hospital, 00029, Helsinki, Finland. 7. Institute of Nutritional Sciences, University of Giessen, Wilhelmstr. 20, 35392, Giessen, Germany. Clemens.Kunz@uni-giessen.de.
Abstract
PURPOSE: Manifestation of allergic disease depends on genetic predisposition, diet and commensal microbiota. Genetic polymorphism of mothers determines their breast milk glycan composition. One major determinant is the fucosyltransferase 2 (FUT2, secretor gene) that was shown to be linked to commensal microbiota establishment. We studied whether FUT2-dependent breast milk oligosaccharides are associated with allergic disease in breast-fed infants later in life. METHODS: We analyzed FUT2-dependent oligosaccharides in breast milk samples of mothers (n = 266) from the placebo group of a randomized placebo-controlled trial of prebiotics and probiotics as preventive against allergic disease in infants with high allergy risk (trial registry number: NCT00298337). Using logistic regression models, we studied associations between FUT2-dependent breast milk oligosaccharides and incidence of allergic disease at 2 and 5 years of age. RESULTS: At 2 years, but not at 5 years of age, we observed a presumed lower incidence (p < 0.1) for IgE-associated eczema manifestation in C-section-born infants who were fed breast milk containing FUT2-dependent oligosaccharides. By logistic regression, we observed a similar relation (p < 0.1) between presence of FUT2-dependent breast milk oligosaccharides and IgE-associated disease and IgE-associated eczema in C-section-born infants only. When testing with the levels of breast milk oligosaccharide 2'-fucosyllactose as proxy for FUT2 activity, we observed significant (p < 0.05) associations in the C-section-born infants with 'any allergic disease,' IgE-associated disease, eczema and IgE-associated eczema. CONCLUSION: The data indicate that infants born by C-section and having a high hereditary risk for allergies might have a lower risk to manifest IgE-associated eczema at 2 years, but not 5 years of age, when fed breast milk with FUT2-dependent milk oligosaccharides. Further studies with larger cohorts and especially randomized controlled intervention trials are required to build on these preliminary observations.
RCT Entities:
PURPOSE: Manifestation of allergic disease depends on genetic predisposition, diet and commensal microbiota. Genetic polymorphism of mothers determines their breast milk glycan composition. One major determinant is the fucosyltransferase 2 (FUT2, secretor gene) that was shown to be linked to commensal microbiota establishment. We studied whether FUT2-dependent breast milk oligosaccharides are associated with allergic disease in breast-fed infants later in life. METHODS: We analyzed FUT2-dependent oligosaccharides in breast milk samples of mothers (n = 266) from the placebo group of a randomized placebo-controlled trial of prebiotics and probiotics as preventive against allergic disease in infants with high allergy risk (trial registry number: NCT00298337). Using logistic regression models, we studied associations between FUT2-dependent breast milk oligosaccharides and incidence of allergic disease at 2 and 5 years of age. RESULTS: At 2 years, but not at 5 years of age, we observed a presumed lower incidence (p < 0.1) for IgE-associated eczema manifestation in C-section-born infants who were fed breast milk containing FUT2-dependent oligosaccharides. By logistic regression, we observed a similar relation (p < 0.1) between presence of FUT2-dependent breast milk oligosaccharides and IgE-associated disease and IgE-associated eczema in C-section-born infants only. When testing with the levels of breast milk oligosaccharide2'-fucosyllactose as proxy for FUT2 activity, we observed significant (p < 0.05) associations in the C-section-born infants with 'any allergic disease,' IgE-associated disease, eczema and IgE-associated eczema. CONCLUSION: The data indicate that infants born by C-section and having a high hereditary risk for allergies might have a lower risk to manifest IgE-associated eczema at 2 years, but not 5 years of age, when fed breast milk with FUT2-dependent milk oligosaccharides. Further studies with larger cohorts and especially randomized controlled intervention trials are required to build on these preliminary observations.
Entities:
Keywords:
Allergy; Breast-feeding; Human milk oligosaccharides; Mode of delivery
Authors: Aurélien Trompette; Eva S Gollwitzer; Koshika Yadava; Anke K Sichelstiel; Norbert Sprenger; Catherine Ngom-Bru; Carine Blanchard; Tobias Junt; Laurent P Nicod; Nicola L Harris; Benjamin J Marsland Journal: Nat Med Date: 2014-01-05 Impact factor: 53.440
Authors: Thomas R Abrahamsson; Hedvig E Jakobsson; Anders F Andersson; Bengt Björkstén; Lars Engstrand; Maria C Jenmalm Journal: J Allergy Clin Immunol Date: 2011-12-06 Impact factor: 10.793
Authors: David S Newburg; Guillermo M Ruiz-Palacios; Mekibib Altaye; Prasoon Chaturvedi; Jareen Meinzen-Derr; Maria de Lourdes Guerrero; Ardythe L Morrow Journal: Glycobiology Date: 2003-11-24 Impact factor: 4.313
Authors: Antti E Seppo; Anna K Kukkonen; Mikael Kuitunen; Erkki Savilahti; Chloe Yonemitsu; Lars Bode; Kirsi M Järvinen Journal: JAMA Pediatr Date: 2019-03-01 Impact factor: 16.193
Authors: Ling Xiao; Belinda Van't Land; Wouter R P H van de Worp; Bernd Stahl; Gert Folkerts; Johan Garssen Journal: Front Immunol Date: 2017-09-28 Impact factor: 7.561
Authors: Daniel Munblit; Diego G Peroni; Alba Boix-Amorós; Peter S Hsu; Belinda Van't Land; Melvin C L Gay; Anastasia Kolotilina; Chrysanthi Skevaki; Robert J Boyle; Maria Carmen Collado; Johan Garssen; Donna T Geddes; Ralph Nanan; Carolyn Slupsky; Ganesa Wegienka; Anita L Kozyrskyj; John O Warner Journal: Nutrients Date: 2017-08-17 Impact factor: 5.717
Authors: Michelle K McGuire; Courtney L Meehan; Mark A McGuire; Janet E Williams; James Foster; Daniel W Sellen; Elizabeth W Kamau-Mbuthia; Egidioh W Kamundia; Samwel Mbugua; Sophie E Moore; Andrew M Prentice; Linda J Kvist; Gloria E Otoo; Sarah L Brooker; William J Price; Bahman Shafii; Caitlyn Placek; Kimberly A Lackey; Bianca Robertson; Susana Manzano; Lorena Ruíz; Juan M Rodríguez; Rossina G Pareja; Lars Bode Journal: Am J Clin Nutr Date: 2017-03-29 Impact factor: 7.045
Authors: Linda P Siziba; Marko Mank; Bernd Stahl; John Gonsalves; Bernadet Blijenberg; Dietrich Rothenbacher; Jon Genuneit Journal: Nutrients Date: 2021-06-08 Impact factor: 5.717